logo
World Wide Farms Partners with ReposiTrak to Strengthen Food Safety and Supply Chain Transparency with End-to-End Traceability

World Wide Farms Partners with ReposiTrak to Strengthen Food Safety and Supply Chain Transparency with End-to-End Traceability

Business Wire22-04-2025

CHICAGO & SALT LAKE CITY--(BUSINESS WIRE)--World Wide Farms, a leading grower, packer, and distributor of fresh culinary herbs and greens, has announced its use of the ReposiTrak Traceability Network® for inbound and outbound traceability data sharing. This collaboration amplifies World Wide Farms' commitment to food safety, regulatory compliance, and supply chain transparency by leveraging ReposiTrak's advanced traceability solution for the exchange of accurate traceability data.​
Founded in 1986 and headquartered in Wauconda, Ill., World Wide Farms has remained dedicated to sustainable farming practices and the delivery of high-quality produce. With operations throughout the United States and Mexico, the company supplies major retailers and food service providers across the Midwest. By adopting the ReposiTrak Traceability Network, World Wide Farms is enhancing its ability to collect and share traceability data in compliance with the FDA's Food Safety Modernization Act (FSMA) 204, set to take effect in 2028.
"At World Wide Farms, our commitment has always been to delivering safe, fresh, and sustainably grown herbs and greens," said Daniel Lyons, President of World Wide Farms. "To uphold that promise, we needed a highly accurate traceability solution for both inbound and outbound shipments. Partnering with ReposiTrak not only positions us well for upcoming regulatory changes – it also enhances our supply chain transparency and boosts operational efficiency."
Every data file received by ReposiTrak is put through a comprehensive 500+ point error detection process to ensure accuracy and consistency. When errors are identified, notifications are sent and ReposiTrak's U.S.-based team works directly with suppliers to make the necessary corrections. This hands-on approach ensures that the data is as accurate as possible before it's shared with World Wide Farms' customers.
"We are thrilled to welcome World Wide Farms to our growing traceability network," said Randy Fields, chairman and CEO of ReposiTrak. "Traceability is a food safety issue that requires a supply chain solution – especially for companies like theirs that are responsible for inbound data from growers and outbound data for customers. Every date file we receive is put through a rigorous set of controls to ensure accuracy BEFORE the data gets stored and/or passed along. It's something that sets us apart and that we're proud to share with World Wide Farms.'
By adopting ReposiTrak's traceability solutions, World Wide Farms is taking a proactive step toward a more resilient and trustworthy food supply chain.​
About World Wide Farms
Founded in 1986 and part of Hoffmann Family of Companies, World Wide Farms is a premier grower, packer, and distributor of fresh culinary herbs and greens. With farming operations in the United States and Mexico, the company is committed to sustainable agriculture and delivering high-quality produce to retailers and food service providers across the Midwest. For more information, visit worldwidefarms.net.​
About ReposiTrak
ReposiTrak (NYSE: TRAK) provides retailers, suppliers and wholesalers with a robust solution suite consisting of three product families: food traceability, compliance and risk management and supply chain solutions. ReposiTrak's integrated, cloud-based applications are supported by an unparalleled team of experts. For more information, please visit repositrak.com.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

TransCon® hGH Boosts TransCon® CNP Results in Kids with Achondroplasia by Week 26
TransCon® hGH Boosts TransCon® CNP Results in Kids with Achondroplasia by Week 26

Yahoo

time40 minutes ago

  • Yahoo

TransCon® hGH Boosts TransCon® CNP Results in Kids with Achondroplasia by Week 26

Ascendis Pharma A/S (NASDAQ:ASND) is among the 13 Biotech Stocks with Huge Upside Potential. It reported interim Week 26 data from its Phase 2 COACH Trial, confirming that combining TransCon hGH (lonapegsomatropin) with TransCon CNP (navepegritide) raised annualized growth velocity (AGV) and height Z-scores in children with achondroplasia. A close-up view of a hand manipulating a syringe while delivering TransCon CNP into a tumor. A mean AGV of 9.14 cm/year and a +0.53 Z-score rise were attained by treatment-naïve youngsters (N=12). Children (N=9) treated with TransCon CNP in the past achieved an AGV of 8.25 cm/year with a +0.44 Z-score improvement. The majority of side effects were modest, and safety remained consistent with monotherapies. The COACH Trial is the first to assess this combination in kids between the ages of two and eleven. While TransCon CNP is undergoing FDA priority review, TransCon hGH is approved as SKYTROFA® for juvenile growth hormone insufficiency. The treatment focuses on the FGFR3-CNP signaling imbalance that is at the heart of achondroplasia, a disorder that affects more than 250,000 people worldwide. It is anticipated that the results of week 52 and a scheduled Phase 3 trial in Q4 2025 will further clarify efficacy and long-term benefits. The biopharmaceutical business Ascendis Pharma A/S (NASDAQ:ASND) uses its TransCon technology platform to significantly improve patient outcomes. While we acknowledge the potential of ASND as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 High-Growth EV Stocks to Invest In and 13 Best Car Stocks to Buy in 2025. Disclosure. None.

Vertex Presents New Data on the Benefits of ALYFTREK
Vertex Presents New Data on the Benefits of ALYFTREK

Yahoo

time40 minutes ago

  • Yahoo

Vertex Presents New Data on the Benefits of ALYFTREK

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of the 13 Biotech Stocks with Huge Upside Potential. The company shared new data at the 48th European Cystic Fibrosis Conference, revealing that ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor) is linked with improved clinical outcomes and quality of life in cystic fibrosis (CF) patients. A pharmacist delivering a specific medication to a patient in a specialty pharmacy. A pooled research found that sweat chloride (SwCl) levels below 60 mmol/L were associated with improved lung function, fewer exacerbations, and better nutritional and quality of life outcomes. Even larger numerical improvements were observed for SwCl below 30 mmol/L. According to post hoc data from Phase 3 trials, ALYFTREK outperformed TRIKAFTA® in terms of health outcomes for adults, adolescents, and children aged 6 to 11. Approximately 109,000 people worldwide, 94,000 of whom live in North America, Europe, and Australia, have cystic fibrosis. The majority of patients have at least one F508del mutation, which is the result of mutations in the CFTR gene. TRIKAFTA® is being donated in 14 lower-income countries, and Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) medications currently serve over 75,000 people in 60+ countries, or almost two-thirds of eligible patients. It is among the stocks with the biggest upside. While we acknowledge the potential of VRTX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 High-Growth EV Stocks to Invest In and 13 Best Car Stocks to Buy in 2025. Disclosure. None. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

Chick-fil-A launches new BBQ sandwich for a limited time in Jacksonville
Chick-fil-A launches new BBQ sandwich for a limited time in Jacksonville

Yahoo

timean hour ago

  • Yahoo

Chick-fil-A launches new BBQ sandwich for a limited time in Jacksonville

Chick-fil-A's Creamy BBQ Sandwich comes to Jacksonville for a limited time starting June 9 through July 19. >>> STREAM ACTION NEWS JAX LIVE << >> STREAM ACTION NEWS JAX LIVE <<< The Creamy BBQ Chicken Sandwich can be delivered on the Chick-fil-A® App or online. However, it cannot be catered. [DOWNLOAD: Free Action News Jax app for alerts as news breaks] Also, members will not be able to redeem points for this sandwich, but can still receive points with their purchase. [DOWNLOAD: Free Action News Jax app for alerts as news breaks] [SIGN UP: Action News Jax Daily Headlines Newsletter] Click here to download the free Action News Jax news and weather apps, click here to download the Action News Jax Now app for your smart TV and click here to stream Action News Jax live.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store